AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-AstraZeneca COVID-19 vaccine.
Mindray is a Chinese multinational medical instrumentation manufacturer based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China’s largest medical device manufacturer.The Patient Monitoring & Life Support division develops and manufactures multi-parameter patient monitors, biotelemetry systems, anesthesia delivery systems, defibrillators, ECG machines, pulse oxymeters, hospital beds, mounting systems and IT solutions. In 2008, Mindray purchased the Patient Monitoring division of Datascope Corporation for $209 million to expand their presence outside of China.
The In-Vitro Diagnostic division provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. This segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories, clinics, and hospitals. Its products include hematology analyzers, biochemistry analyzers, reagents, a microplate reader and a microplate washer.
The CUHK Medical Centre (CUHKMC) is a non-profit, private teaching hospital wholly owned by The Chinese University of Hong Kong (CUHK). With a social mission to bridge the service gaps between private and public healthcare in Hong Kong, CUHKMC is dedicated to offering quality healthcare service at affordable and transparent package prices. In line with the not-for-profit principle, all surpluses from all healthcare services will be ploughed back to the hospital for hospital development and the CUHK Faculty of Medicine for research and teaching.
HISKY is a national high-level talent pioneering enterprise, an innovative and pioneering talent enterprise in Jiangsu Province, a doctoral concentration plan enterprise in Jiangsu Province, and a Top-530 enterprise in Wuxi. Its entrepreneur team consists of doctors from Tsinghua University and executives with many years of medical device marketing experience. It is a high-tech enterprise focusing on the development and promotion of high-end medical technologies. It has reached the international advanced level in the field of non-invasive detection of liver elasticity compared with the previous fat detection. It is a leading brand in the field of non-invasive detection of liver health in China. It owns the series products of FIBROTOUCH and iLivTouch. It has nearly 300 patents and has published hundreds of papers. It has obtained US FDA and EU CE certification. At present, it has sold its products to more than 1,000 well-known medical institutions in China and exported products to over 20 countries around the world.
One of the world’s leading manufacturers for ultrasound systems. In its 23 years of history, CHISON adheres to independent research and development. Approved as High-Tech Enterprise by Jiangsu Technology Department, now CHISON has two R&D centers in China (Wuxi, Jiangsu) & US (Seattle, WA). The R&D headquarter is awarded as National Competent Enterprise on Intellectual Property Rights, High-Tech Enterprise and Jiangsu Engineering Technology Research Center. Besides, nominated as national R&D project leader supported by China’s 12th &13th 5-Year Plan, CHISON has become a leading enterprise in China’s ultrasound industry.
The 3M Company is an American multinational conglomerate corporation operating in the fields of industry, worker safety, US health care, and consumer goods. The company produces over 60,000 products under several brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software, and optical films. It is based in Maplewood, a suburb of Saint Paul, Minnesota.
Headway Bio-Sci & Tech Co., Ltd. is a high-tech enterprise which owns completely independent intellectual property rights of breath test technology and integrates research, development, production and sales in China. Relying on the resources and advantages of China Isotope & Radiation Corporation — the application platform of nuclear technology for China National Nuclear Corporation (CNNC), it has been focusing on the application and innovation of breath test technology in combination with the innovation achievements of atomic energy technology. The company is specialized in the development, production and sales of Urea breath test kits and analysis instruments for diagnosing Helicobacter pylori infection in patients.